Singular Genomics Systems, Inc. (OMIC)
NASDAQ: OMIC · Real-Time Price · USD
21.68
+0.16 (0.74%)
Nov 20, 2024, 4:00 PM EST - Market closed

Singular Genomics Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
2.672.910.77---
Revenue Growth (YoY)
2.77%280.52%----
Cost of Revenue
4.023.470.79---
Gross Profit
-1.35-0.56-0.02---
Selling, General & Admin
46.2752.5847.2628.626.292.29
Research & Development
43.4847.7646.232.6621.2510.48
Operating Expenses
89.75100.3493.4661.2827.5312.77
Operating Income
-91.1-100.9-93.49-61.28-27.53-12.77
Interest Expense
-1.14-1.1-0.76-0.85-0.72-0.02
Interest & Investment Income
7.839.083.370.730.460.41
Other Non Operating Income (Expenses)
----2.18-0.160.05
EBT Excluding Unusual Items
-84.42-92.92-90.88-63.57-27.95-12.33
Gain (Loss) on Sale of Investments
-----0.01
Asset Writedown
-1.9-1.9----
Other Unusual Items
----35.2--
Pretax Income
-86.32-94.82-90.88-98.77-27.95-12.32
Net Income
-86.32-94.82-90.88-98.77-27.95-12.32
Net Income to Common
-86.32-94.82-90.88-98.77-27.95-12.32
Shares Outstanding (Basic)
222200
Shares Outstanding (Diluted)
222200
Shares Change (YoY)
3.35%2.32%51.30%344.62%22.69%-
EPS (Basic)
-34.77-39.08-38.32-63.01-79.27-42.89
EPS (Diluted)
-34.77-39.08-38.40-63.01-79.27-42.89
Free Cash Flow
-80.86-74.62-93.12-56.57-26.25-12.2
Free Cash Flow Per Share
-32.57-30.75-39.26-36.09-74.47-42.46
Gross Margin
-50.77%-19.17%-3.14%---
Operating Margin
-3415.97%-3466.20%-12220.52%---
Profit Margin
-3236.67%-3257.30%-11879.61%---
Free Cash Flow Margin
-3031.72%-2563.28%-12172.03%---
EBITDA
-86.98-97.39-91.06-60.15-26.9-12.42
D&A For EBITDA
4.133.512.431.130.640.35
EBIT
-91.1-100.9-93.49-61.28-27.53-12.77
Source: S&P Capital IQ. Standard template. Financial Sources.